Filing
Spy
Filing
Spy
Home
About
AKBA
Akebia Therapeutics Inc
Biopharmaceutical company
CUSIP: 00972D105
Healthcare
US
2 holders
Ownership
Activity
Fundamentals
2019 Q2
8 of 11 quarters
Total Value
$145.82M
Total Shares
30.13M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$118.44M
24.47M
1.1%
Unchanged
Baupost Group LLC
$118.44M
24.47M shares
Unchanged
Abrams Capital Management
$27.38M
5.66M
0.7%
Unchanged
Abrams Capital Management
$27.38M
5.66M shares
Unchanged
AKBA — Akebia Therapeutics Inc - FilingSpy